sunitinib eg 12.5 mg gél.
eg sa-nv - sunitinib 12,5 mg - gélule - 12,5 mg - sunitinib 12.5 mg - sunitinib
sunitinib eg 25 mg gél.
eg sa-nv - sunitinib 25 mg - gélule - 25 mg - sunitinib 25 mg - sunitinib
sunitinib eg 37.5 mg gél.
eg sa-nv - sunitinib 37,5 mg - gélule - 37,5 mg - sunitinib 37.5 mg - sunitinib
sunitinib eg 50 mg gél.
eg sa-nv - sunitinib 50 mg - gélule - 50 mg - sunitinib 50 mg - sunitinib
artesunate amivas
amivas ireland ltd - artesunate - paludisme - antiprotozoaires - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. la considération devrait être donnée à des recommandations officielles concernant l'utilisation appropriée des agents antipaludiques.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agents antinéoplasiques - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib krka 12,5 mg gél.
krka d.d. novo mesto d.d. - malate de sunitinib 16,71 mg - eq. sunitinib 12,5 mg - gélule - 12,5 mg - malate de sunitinib 16.71 mg - sunitinib
sunitinib krka 25 mg gél.
krka d.d. novo mesto d.d. - malate de sunitinib 33,41 mg - eq. sunitinib 25 mg - gélule - 25 mg - malate de sunitinib 33.41 mg - sunitinib
sunitinib krka 50 mg gél.
krka d.d. novo mesto d.d. - malate de sunitinib 66,83 mg - eq. sunitinib 50 mg - gélule - 50 mg - malate de sunitinib 66.83 mg - sunitinib
sunitinib mylan 37,5 mg, gélule
mylan sas - sunitinib - gélule - 37,5 mg - composition pour une gélule > sunitinib : 37,5 mg - agent antinéoplasique, inhibiteur de protéine kinase